Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
1.0%
1w
3.2%
1m
5.4%
3m
9.7%
6m
10.1%
1y
1.3%
5y
13.3%
10y
19.2%
all
26.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 27,960 1.0%
27,550
31,396
Company Overview

Sales
6,714 Cr
Growth: 10.1%
Profit after Tax
1,509 Cr
Growth: 3.9%
Large Cap
59,412 Cr
P/E: 39.4x
Industry P/E: 33.1x
Fundamentals

Sales (Cr) ₹ 6,714
Growth 10.1%
EBITDA 27.0%
P/S 8.8x
Dividend 1.4%
P/E 39.4x
Book Value ₹ 2,360
PEG Ratio 3.9x
ROE 32.5%
P/B 11.8x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.Products and Services offered by the companyCardiovascular- Keeping heart healthy with breakthrough medical technologies.Diabetes- Helping people with diabetes enjoy healthier, active lives.
Investors (50)
Followers (16)